TP53 and prostate carcinoma: This research group subsequently depleted or knocked down Akt or Raptor (an essential component of the mTORC1 complex) in PTEN/p53 double-deficient MEFs or the prostate cancer cell line UMN-4240P, resulting in a significant reduction in HK-II protein expression.